abstract |
Compounds are described which are useful for lowering the activity of alpha 2-PI, for the treatment of myocardial infarctions and cerebral infarctions, as urokinase secretion accelerators, as antithrombotic agents and to accelerate the fibrinolysis accelerating effect. |